Lunit receives $26M funding from Guardant Health
South Korean artificial intelligence (AI) software developer Lunit recentl...Read more on AuntMinnie.comRelated Reading:
Lunit highlights Karolinska AI studies
Lunit partners with Philips on chest AI software
Lunit, Infinitt partner on Indonesian distribution deal
Lunit touts study for COVID-19 imaging
Lunit highlights AI lung cancer detection research (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 20, 2021 Category: Radiology Source Type: news
FDA Approves Tacrolimus for Lung Transplants FDA Approves Tacrolimus for Lung Transplants
The drug is the only immunosuppressant approved for the prevention of organ rejection in both adult and pediatric patients undergoing lung transplant. It has been used in lung transplant for 15 years.FDA Approvals (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - July 19, 2021 Category: Surgery Tags: Transplantation News Alert Source Type: news
Unvaccinated Georgia man underwent DOUBLE LUNG transplant after contracting COVID-19
Blake Bargatze, 24, from Sugar Hill, Georgia, who did not a vaccine over fears of side effects recently underwent a double lung transplant after he contracted COVID-19. (Source: the Mail online | Health)
Source: the Mail online | Health - July 15, 2021 Category: Consumer Health News Source Type: news
What Problems are Ciliopathies Associated With?
Discussion
Nephronophthisis (NPHP) one cause of end-stage renal disease (ESRD) usually occurring before age 30 years. NPHP is a non-motile ciliopathy affecting cellular sensing in the renal tubular epithelium. See To Learn More below.
The incidence varies according to location with 1:1 million in the US but 1:50,000 in Finland.
There are 3 subtypes:
Infantile
Occurs usually within 1 year of life
Enlarged kidneys and severe hypertension
In utero can have oligohydramnios problems such as pulmonary hypoplasia, facial dysmorphisms, limb contractures
Extra-renal problems include congenital heart disease, liver fibrosis, recur...
Source: PediatricEducation.org - July 5, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
NIDCR's Summer 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page.
NIDCR's Summer 2021 E-Newsletter
In this issue:
NIDCR News
Funding Opportunities & Related Notices
NIH/HHS News
Subscribe to NICDR News
Science Advances
Grantee News
NIDCR News
NIDCR to Release Report on Oral Health in America
As a 20-year follow-up to the seminal Oral Health in America: A Report of the Surgeon General, NIDCR will release Oral Health in America: Advances and Challenges in the fall of 2021. The report will illuminate new directions...
Source: NIDCR Science News - July 1, 2021 Category: Dentistry Source Type: news
For transplant patients, COVID-19 vaccination presents a different uncertainty
(University of California - San Diego) Researchers at UC San Diego Health have launched a pair of clinical trials to study the immune response of COVID-19 vaccinated transplant recipients of bone marrow and solid organs, such as the heart, lung, liver and kidney. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 1, 2021 Category: Infectious Diseases Source Type: news
Vuno inks deal with Samsung integrating AI with mobile x-ray
South Korean artificial intelligence (AI) developer Vuno has signed a deal wit...Read more on AuntMinnie.comRelated Reading:
Vuno goes public in South Korea
Vuno signs deal for AI sales in Taiwan
EOS installs 1st EOSedge system in Australia
Vuno AI system for lung CT gets approved in South Korea
Report: Samsung to sell in vitro diagnostics unit (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 30, 2021 Category: Radiology Source Type: news
Vuno inks deal with Samsung
South Korean artificial intelligence (AI) developer Vuno has signed a deal wit...Read more on AuntMinnie.comRelated Reading:
Vuno goes public in South Korea
Vuno signs deal for AI sales in Taiwan
EOS installs 1st EOSedge system in Australia
Vuno AI system for lung CT gets approved in South Korea
Report: Samsung to sell in vitro diagnostics unit (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 30, 2021 Category: Radiology Source Type: news
Fast IR imaging-based AI identifies tumor type in lung cancer
(Ruhr-University Bochum) The prognosis and effective therapies differ based on the type of lung cancer. While it previously took several days to precisely determine the underlying mutation, a research team at the Centre for Protein Diagnostics (PRODI) at Ruhr-Universit ä t Bochum (RUB) has been able to reliably perform this determination in just one step using a combination of quantum cascade laser-based infrared microscopy and artificial intelligence. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2021 Category: Cancer & Oncology Source Type: news
What Types of New Therapies are Available for Cystic Fibrosis?
Discussion
Cystic fibrosis (CF) was identified in 1938 by Dr. Dorothy Andersen who described 49 patients with pancreatic insufficiency. Since that time significant achievements in the knowledge about the disease and treatments for patients have changed the mortality from a few months to patients living into middle adulthood or even later. Quality of life for patients and their families and friends has also markedly improved.
CF is the classic Mendelian autosomal recessive genetic disorder which is a worldwide disorder but affects people of north European ancestry more often where the main mutation is more common. There are...
Source: PediatricEducation.org - June 28, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Janssen Submits New Drug Application to U.S. FDA for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, June 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of XARELTO® (rivaroxaban) in pediatric patients. The NDA seeks two pediatric indications: treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients aged birth to less than 18 years of age after at least five days of initial parenteral anticoagulant treatment; and thromboprophylaxis (prevention of blood clots) in patients aged 2 years and older with co...
Source: Johnson and Johnson - June 23, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Man Refusing COVID Vaccine Later Needs Lung Transplant Man Refusing COVID Vaccine Later Needs Lung Transplant
"If I knew what I know now, I would have definitely went through with the vaccination," he said.WebMD Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - June 18, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news
Janssen Highlights Commitment to Advancing Transformative Innovations in Oncology with Scientific Updates from Deep, Diverse Pipeline and Portfolio at ASCO and EHA Virtual Scientific Programs
June 1, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 30 company-sponsored studies, including six oral presentations, will be featured during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8. Janssen presentations will include new data and updates for both approved and investigational therapeutics that are being studied for the treatment of various solid tumors and blood cancers. Immediately following ASCO, additional data will be featured during the European Hematology Association (EHA) Virtual Congress, June 9-17. A ...
Source: Johnson and Johnson - June 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
AI with swarm intelligence
(DZNE - German Center for Neurodegenerative Diseases) Researchers led by the German Center for Neurodegenerative Diseases (DZNE) have used " swarm learning " - a novel, artificial intelligence technology - to detect blood cancer, lung diseases and COVID-19 in data stored in a decentralized fashion. Their findings are reported in " Nature " . (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 26, 2021 Category: Infectious Diseases Source Type: news
COVID-19 in Lung Transplant Recipients: A Multicenter Study COVID-19 in Lung Transplant Recipients: A Multicenter Study
This study provides new insights into the presentation and outcomes of COVID-19 among lung transplant recipients. How should these patients be treated?American Journal of Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 21, 2021 Category: Consumer Health News Tags: Transplantation Journal Article Source Type: news
AI predicts lung cancer risk
(Radiological Society of North America) An artificial intelligence program accurately predicts the risk that lung nodules detected on screening CT will become cancerous, according to a new study. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 18, 2021 Category: Cancer & Oncology Source Type: news
Late-Breaking Data at ACC.21 Show XARELTO ® (rivaroxaban) Plus Aspirin Significantly Reduced Total Ischemic Events in Peripheral Artery Disease (PAD) Patients After Lower-Extremity Revascularization
RARITAN, N.J., May 16, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today presented new data from the Phase 3 VOYAGER PAD study which showed XARELTO® (rivaroxaban) (2.5 mg twice daily) in combination with aspirin (100 mg once daily) consistently reduced severe vascular events in patients with peripheral artery disease (PAD) after lower-extremity revascularization (LER) compared to aspirin alone regardless of whether it was the first, second, third, or subsequent event. The primary results of VOYAGER PAD showed that XARELTO® plus aspirin reduced first events by 15 percent among patients...
Source: Johnson and Johnson - May 16, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Ventilating the rectum to support respiration
(Tokyo Medical and Dental University) Researchers from Tokyo Medical and Dental University (TMDU) have demonstrated that delivering oxygen via the rectum as a gas or in an oxygen-rich liquid can support oxygen provision to organs and tissues during respiratory failure. Such " enteral ventilation " increased oxygenation, improved behavior and prolonged survival in experimental mouse and pig models of respiratory failure. Further research may allow its clinical application in human patients as a less invasive alternative to ventilators and artificial lungs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 14, 2021 Category: International Medicine & Public Health Source Type: news
Gene therapy offers potential cure to children born without an immune system
An experimental form of gene therapy developed by a team of researchers from UCLA and Great Ormond Street Hospital in London has successfully treated 48 of 50 children born with a rare and deadly inherited disorder that leaves them without an immune system.Severe combined immunodeficiency due to adenosine deaminase deficiency, or ADA-SCID, is caused by mutations in theADA gene that creates the enzyme adenosine deaminase, which is essential to a functioning immune system.For children with the condition, even day-to-day activities like going to school or playing with friends can lead to dangerous, life-threatening infections...
Source: UCLA Newsroom: Health Sciences - May 11, 2021 Category: Universities & Medical Training Source Type: news
Molecular analysis identifies key differences in lungs of cystic fibrosis patients
A team of researchers from UCLA, Cedars-Sinai and the Cystic FibrosisFoundation has developed a first-of-its-kind molecular catalog of cells in healthy lungs and the lungs of people with cystic fibrosis.The catalog,described today in the journal Nature Medicine, reveals new subtypes of cells and illustrates how the disease changes the cellular makeup of the airways. The findings could help scientists in their search for specific cell types that represent prime targets for genetic and cell therapies for cystic fibrosis.“This new research has provided us with valuable insights into the cellular makeup of both heal...
Source: UCLA Newsroom: Health Sciences - May 7, 2021 Category: Universities & Medical Training Source Type: news
A Free & Accessible Vaccine is Just out of Reach for Palestinians
Young Palestinians drive their boat along the coast near the Gaza Sea port, selling boat rides as a way to earn a living. Credit: Laila Barhoum/ Oxfam By Laila BarhoumGAZA, Apr 29 2021 (IPS) We were able to keep the coronavirus at bay for five months in Gaza, the densely populated Palestinian strip of land surrounded by Israel that I call home. But the Coronavirus doesn’t respect walls or artificial borders. While preparations were made for the pandemic to inevitably breach a blockade so few Palestinians can, we waited for it to come for us. And it did.
In one of the most sealed off places in the world, we knew the ...
Source: IPS Inter Press Service - Health - April 29, 2021 Category: International Medicine & Public Health Authors: Laila Barhoum Tags: Aid Development & Aid Featured Global Headlines Health Human Rights Humanitarian Emergencies TerraViva United Nations Source Type: news
AI detects ARDS equal to experts
An artificial intelligence (AI) algorithm has been trained to achieve exper...Read more on AuntMinnie.comRelated Reading:
Study finds chest x-ray 'through glass' valuable during COVID-19
Daily chest x-rays not needed in COVID-19 patients
IBM releases chest x-ray dataset for algorithm training
Curbing daily use of chest x-ray in ICU cuts major costs
AI detects more malignant lung nodules on x-rays (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 23, 2021 Category: Radiology Source Type: news
Management of Lung Transplantation in the COVID-19 Era Management of Lung Transplantation in the COVID-19 Era
A survey of transplant centers provides insight into the impacts of the COVID-19 pandemic on lung transplant programs and transplant recipients.American Journal of Transplantation (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - April 21, 2021 Category: Transplant Surgery Tags: Transplantation Journal Article Source Type: news
AI can help predict mortality from metastatic breast cancer
An artificial intelligence (AI) algorithm can expertly detect metastatic lun...Read more on AuntMinnie.comRelated Reading:
PET aids in treatment of metastatic breast cancer patients
Single-session SBRT speeds treatment of lung metastases
PET/MRI ups lesion detection by 15% for some cancers
FES-PET enhances treatment for metastatic breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 20, 2021 Category: Radiology Source Type: news
Lunit highlights Karolinska AI studies
Lunit is claiming that its artificial intelligence (AI) algorithm showed grea...Read more on AuntMinnie.comRelated Reading:
Lunit partners with Philips on chest AI software
Lunit, Infinitt partner on Indonesian distribution deal
Lunit touts study for COVID-19 imaging
Lunit highlights AI lung cancer detection research
Lunit touts AI mammography studies (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 16, 2021 Category: Radiology Source Type: news
Mayo Clinic Q and A: How lung restoration improves organ availability
DEAR MAYO CLINIC: I was reading about lung restoration and innovation in the field of lung transplantation. Can you share more about this? ANSWER: Over the past several years, devices outside the body have been used to evaluate human lungs donated for organ transplant before the lungs are transplanted. In the future, lung restoration may increasingly be [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 16, 2021 Category: Databases & Libraries Source Type: news
Scientists Report Creating the First Embryo With Human and Non-Human Primate Cells
In a ground-breaking experiment, researchers have successfully created the first human-monkey chimera. The work, published in the journal Cell, describes the the first embryo containing both human and monkey cells that was cultured for 20 days. Led by Juan Carlos Izpisua Belmonte, the study represents the culmination of decades of work in understanding early embryo development in non-human species, which Belmonte hopes will now apply to humans. But it is bound to raise serious ethical questions about the implications of combining human cells with those from a different species (even if it is a closely related one), and the...
Source: TIME: Health - April 15, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Source Type: news
First Living Donor Transplant of Lung Tissue to COVID - 19 Patient Announced
Female recipient received lung tissue donated by her husband and son (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - April 10, 2021 Category: Respiratory Medicine Tags: Infections, Pulmonology, Surgery, Institutional, Source Type: news
First Living Donor Transplant of Lung Tissue to COVID-19 Patient Announced
FRIDAY, April 9, 2021 -- The world's first transplant of lung tissue from living donors to a COVID-19 patient with severe lung damage was announced Thursday by doctors in Japan.
In the 11-hour operation at Kyoto University on Wednesday, the female... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 9, 2021 Category: Pharmaceuticals Source Type: news
Transplant Saves Selected Patients With Irreversible COVID-19 Lung Disease Transplant Saves Selected Patients With Irreversible COVID-19 Lung Disease
Double lung transplants are the only known way to save the lives of people with acute respiratory distress syndrome and irreversible lung damage from COVID-19, a new study shows.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - April 9, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news
COVID-19 Patient Receives Lung Transplant From Living Donors
TOKYO — Doctors in Japan announced Thursday they have successfully performed the world’s first transplant of lung tissue from living donors to a patient with severe lung damage from COVID-19.
The recipient, identified only as a woman from Japan’s western region of Kansai, is recovering after the nearly 11-hour operation on Wednesday, Kyoto University Hospital said in a statement. It said her husband and son, who donated parts of their lungs, are also in stable condition.
The university said it was the world’s first transplant of lung tissue from living donors to a person with COVID-19 lung damage. T...
Source: TIME: Health - April 9, 2021 Category: Consumer Health News Authors: MARI YAMAGUCHI / AP Tags: Uncategorized COVID-19 overnight wire Source Type: news
Moderna vaccine antibodies last at least 6 months; lung transplant can save some COVID-19 survivors
Earlier this month, Pfizer Inc and partner BioNTech SE said their vaccine using similar messenger RNA (mRNA) technology remained highly effective for at least six months. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 9, 2021 Category: Pharmaceuticals Source Type: news
COVID-19 patient receives lung transplant from living donors
Doctors in Japan say they have successfully performed the world’s first transplant of lung tissue from living donors to a patient with severe lung damage from COVID-19 (Source: ABC News: Health)
Source: ABC News: Health - April 8, 2021 Category: Consumer Health News Tags: Health Source Type: news
Canada's Hospitals Deploy Artificial Lungs, Scramble for Staff as COVID-19 Hits Younger Patients Canada's Hospitals Deploy Artificial Lungs, Scramble for Staff as COVID-19 Hits Younger Patients
Younger Canadians are bearing the brunt of the nation's latest COVID-19 surge, creating growing demand for artificial lungs and a struggle to maintain staffing in critical care units as hospitals make last-ditch efforts to save patients.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - April 7, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news
Imbio signs Heart&Lung Health in U.K.
Artificial intelligence software developer Imbio has signed a deal with U.K...Read more on AuntMinnie.comRelated Reading:
Imbio nets FDA nod for RV/LV Analysis AI algorithm
Aidoc and Imbio team up on AI for pulmonary embolism
Siemens adds Imbio AI apps to syngo.via platform
Imbio teams up with Genentech for AI in lung disease
Imbio adds analysis software to Nuance AI marketplace (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 6, 2021 Category: Radiology Source Type: news
First US trachea transplant offers hope to Covid patients with windpipe damage
Social worker, 56, treated at Mt Sinai hospital in New YorkSome patients left with serious damage from ventilatorsSurgeons in New York City have performed the first windpipe transplant in the US, giving a woman who suffered severe asthma a new trachea, the tube that transports air from the mouth to the lungs.Doctors say such operations could help Covid-19 patients left with serious windpipe damage from breathing machines.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 6, 2021 Category: Science Authors: Associated Press in New York Tags: Medical research Science US healthcare US news Source Type: news
New Real-World Observational Analysis of UPTRAVI ® (selexipag) Underscores the Importance of Risk Assessment for Treating Pulmonary Arterial Hypertension (PAH) Patients
SOUTH SAN FRANCISCO, CA – April 6, 2021 – Findings from an analysis of the first 500 patients enrolled in the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry) found more than three-quarters (76%) of pulmonary arterial hypertension (PAH) patients treated with UPTRAVI® (selexipag) either maintained (56%) or reduced (20%) their one-year mortality risk score. The SPHERE results were published in the April issue of the Journal of Heart and Lung Transplantation (JHLT). SPHERE is an ongoing real-world, observational, user registry using two different risk assessment methods that describes the clinical characte...
Source: Johnson and Johnson - April 6, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Researchers evaluate deep learning for breast ultrasound
Researchers from China evaluated the use of artificial intelligence (AI) algorithm...Read more on AuntMinnie.comRelated Reading:
Nico.Lab partners with AI Advance for distribution
Radiomics AI algorithm differentiates sclerotic bone lesions
iCAD touts breast screening study
IBM releases chest x-ray dataset for algorithm training
Nines wins FDA clearance for AI lung nodule measurement (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 6, 2021 Category: Radiology Source Type: news
Criteria for selecting COVID-19 patients for lung lung transplantation
(Medical University of Vienna) The Vienna lung transplantation programme plays a leading role in an international consortium comprising experts from the USA, Europe and Asia. Approximately 40 transplants have now been carried out on Covid-19 patients throughout the world. In a study the consortium has now proposed the first general selection criteria for lung transplantation in Covid-19 patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 2, 2021 Category: International Medicine & Public Health Source Type: news
UC group launches clinical trial using CRISPR to correct sickle cell disease gene defect
Scientists at UCLA, UC San Francisco and UC Berkeley have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patients ’ own blood-forming stem cells.The trial will combine CRISPR technology developed at the Innovative Genomics Institute — a UC Berkeley–UCSF initiative founded by Berkeley’s Nobel Prize–winning scientist Jennifer Doudna — with UCLA’s expertise in genetic analysis and cell manufacturing, and the decades-long expertise at U...
Source: UCLA Newsroom: Health Sciences - March 30, 2021 Category: Universities & Medical Training Source Type: news
Liesbeth Stoeffler, 61, Runner Kept Going by Rare Lung Treatment, Dies
A machine that acted as an artificial lung kept her eligible for a transplant as she dealt with cystic fibrosis. She went on to compete again in marathons. (Source: NYT Health)
Source: NYT Health - March 26, 2021 Category: Consumer Health News Authors: Richard Sandomir Tags: Cystic Fibrosis Coronavirus (2019-nCoV) Ventilators (Medical) Lungs Running AllianceBernstein Holding LP Austria Manhattan (NYC) Stoeffler, Liesbeth (1959-2021) Transplants Source Type: news
3D-printed artificial lung model
(Pohang University of Science& Technology (POSTECH)) POSTECH develops an artificial lung model applicable as a respiratory disease treatment platform. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 25, 2021 Category: Biology Source Type: news
FDA clears Optellum's lung cancer diagnosis software
The U.S. Food and Drug Administration (FDA) has cleared artificial intelligenc...Read more on AuntMinnie.comRelated Reading:
Optellum, Mirada present lung cancer study at RSNA 2017
Optellum unveils lung cancer analysis software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 23, 2021 Category: Radiology Source Type: news
Survivor: Woman With COVID-19 Gives Birth, Gets New Lungs Survivor: Woman With COVID-19 Gives Birth, Gets New Lungs
A suburban Detroit woman infected with COVID-19 gave birth then underwent a double lung transplant just weeks later to save her life, doctors said Wednesday.Associated Press (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - March 18, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news
Imbio nets FDA nod for RV/LV Analysis AI algorithm
Artificial intelligence (AI) software developer Imbio has garnered U.S. Foo...Read more on AuntMinnie.comRelated Reading:
Aidoc and Imbio team up on AI for pulmonary embolism
New AI lab at UMass focuses on thoracic imaging
Siemens adds Imbio AI apps to syngo.via platform
Imbio teams up with Genentech for AI in lung disease
Imbio adds analysis software to Nuance AI marketplace (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 16, 2021 Category: Radiology Source Type: news
AI reduces FDG dose on PET imaging
An artificial intelligence (AI) algorithm can process F-18 FDG PET exams acquire...Read more on AuntMinnie.comRelated Reading:
FDG-PET/MRI offers option for pediatric Hodgkin lymphoma
FDG-PET/CT shows COVID-19 vaccine uptake
Radiomics, AI can guide NSCLC treatment decisions
PET/CT guidance offers valuable approach to lung biopsies
PET/MRI, CT predict pancreatic cancer treatment response (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 12, 2021 Category: Radiology Source Type: news
Lunit partners with Philips on chest AI software
Artificial intelligence (AI) software developer Lunit is making its chest imagin...Read more on AuntMinnie.comRelated Reading:
Philips forms ultrasound AI partnership with DiA
Can radiology AI save itself?
AI improves lung cancer detection on x-rays
Lunit touts study for COVID-19 imaging
Lunit highlights AI lung cancer detection research (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 4, 2021 Category: Radiology Source Type: news
Vuno goes public in South Korea
South Korean artificial intelligence developer Vuno has gone public after th...Read more on AuntMinnie.comRelated Reading:
Vuno signs deal for AI sales in Taiwan
Vuno gets Korean designation for AI cardiac software
Vuno AI system for lung CT gets approved in South Korea
Vuno wins Korean approval for chest AI tool
AI algorithm speeds up assessment of bone age (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 26, 2021 Category: Radiology Source Type: news
AI can predict malignancy for multiple pulmonary nodules
An artificial intelligence (AI) algorithm was able to predict the risk of cance...Read more on AuntMinnie.comRelated Reading:
AI enhances performance of CT lung cancer screening
How high a price for incidental lung nodules on CT?
CT radiomics classifies small nodules found in CT lung screening
Gaps in lung nodule follow-up linked to racial disparities
Can AI software drive CT lung screening rates higher? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 25, 2021 Category: Radiology Source Type: news
Woman Dies After Getting Covid-19 From Transplanted Lungs
In what appears to be the first case of its kind, a pair of donated lungs led to Covid-19 in an organ recipient, according to doctors at the University of Michigan. (Source: NYT Health)
Source: NYT Health - February 24, 2021 Category: Consumer Health News Authors: Jacey Fortin Tags: Coronavirus (2019-nCoV) Transplants Organ Donation Michigan Lungs Surgery and Surgeons American Journal of Transplantation United Network for Organ Sharing Deaths (Fatalities) Source Type: news
